PROVETOP

Human/Mouse BMPR2 Protein

Catalog No: BMPR2-HF001

Species
Human/Mouse
Expression System
HEK293
Tag
an hFc (IgG1)

Product overview

Recombinant Human/Mouse BMPR2 Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Ser27-Thr150 (accession: Q13873-1(Human) / O35607(Mouse)).

Product Details

Molecular Aliases
BMPR-2; BMPR-II; PPH1;BMPR2
Protein Length
Ser27-Thr150
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 39.84 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
BMPR2-HF001 Bis-Tris-PAGE-white result

Human/Mouse BMPR2 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
BMPR2-HF001 SEC-HPLC result

The purity of Human/Mouse BMPR2 is greater than 95% as determined by SEC-HPLC.

Background

Bone morphogenetic protein type 2 receptor (BMPR2) is one of the transforming growth factor-β (TGF-β) superfamily receptors, performing diverse roles during embryonic development, vasculogenesis, and osteogenesis. Human BMPR2 consists of 1,038 amino acids, and contains functionally conserved extracellular, transmembrane, kinase, and C-terminal cytoplasmic domains. Bone morphogenetic proteins (BMPs) engage the tetrameric complex, composed of BMPR2 and its corresponding type 1 receptors, which initiates SMAD proteins-mediated signal transduction leading to the expression of target genes implicated in the development or differentiation of the embryo, organs and bones.

References

  1. Kim MJ, Park SY, Chang HR, Jung EY, Munkhjargal A, Lim JS, Lee MS, Kim Y. Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2. BMB Rep. 2017 Jun;50(6):308-317. doi: 10.5483/bmbrep.2017.50.6.059. PMID: 28391780; PMCID: PMC5498141.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support